SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Lynda Coughlan, Caitlin Mullarkey, Sarah Gilbert, Adenoviral vectors as novel vaccines for influenza, Journal of Pharmacy and Pharmacology, 2015, 67, 3
  2. 2
    Florian Krammer, Peter Palese, Advances in the development of influenza virus vaccines, Nature Reviews Drug Discovery, 2015, 14, 3, 167

    CrossRef

  3. 3
    Florian Krammer, Emerging influenza viruses and the prospect of a universal influenza virus vaccine, Biotechnology Journal, 2015, 10, 4
  4. 4
    Anwar M. Hashem, Prospects of HA-Based Universal Influenza Vaccine, BioMed Research International, 2015, 2015, 1

    CrossRef

  5. 5
    Carolien E. van de Sandt, Joost H.C.M. Kreijtz, Martina M. Geelhoed-Mieras, Stella E. Vogelzang-van Trierum, Nella J. Nieuwkoop, David A.M.C. van de Vijver, Ron A.M. Fouchier, Albert D.M.E. Osterhaus, Bror Morein, Guus F. Rimmelzwaan, Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine, Vaccine, 2014, 32, 43, 5614

    CrossRef

  6. 6
    Chunfeng Li, Qi Ba, Aiping Wu, Hong Zhang, Tao Deng, Taijiao Jiang, A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly, FEBS Journal, 2013, 280, 4
  7. You have full text access to this Open Access content7
    Sarah C. Gilbert, Advances in the development of universal influenza vaccines, Influenza and Other Respiratory Viruses, 2013, 7, 5
  8. 8
    Alper Azak, Bülent Huddam, Gülay Kocak, A Basak Altas, Murat Duranay, Gülay Korukluoglu, Antibody Response After Single H1N1 Influenza Vaccine in Chronic Dialysis Patients, Therapeutic Apheresis and Dialysis, 2013, 17, 1
  9. 9
    Andrea Orsi, Filippo Ansaldi, Daniela de Florentiis, Antonella Ceravolo, Valentina Parodi, Paola Canepa, Martina Coppelli, Giancarlo Icardi, Paolo Durando, Cross-protection against drifted influenza viruses, Human Vaccines & Immunotherapeutics, 2013, 9, 3, 582

    CrossRef

  10. 10
    Lidia B. Brydak, Effectiveness of influenza vaccine in patients on hemodialysis – a review, Medical Science Monitor, 2013, 19, 1013

    CrossRef

  11. 11
    Filippo Ansaldi, Andrea Orsi, Daniela de Florentiis, Valentina Parodi, Emanuela Rappazzo, Martina Coppelli, Paolo Durando, Giancarlo Icardi, Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60, Human Vaccines & Immunotherapeutics, 2013, 9, 3, 591

    CrossRef

  12. You have full text access to this Open Access content12
    Natalija Budimir, Aalzen Haan, Tjarko Meijerhof, Emma Gostick, David A. Price, Anke Huckriede, Jan Wilschut, Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration, Influenza and Other Respiratory Viruses, 2013, 7, 6
  13. 13
    Ljiljana Trtica-Majnaric, Improving Influenza Vaccination Rates— A Straightforward Task or a Multifaceted Challenge?, World Journal of Vaccines, 2013, 03, 02, 60

    CrossRef

  14. 14
    Florian Krammer, Peter Palese, Influenza virus hemagglutinin stalk-based antibodies and vaccines, Current Opinion in Virology, 2013, 3, 5, 521

    CrossRef

  15. You have full text access to this Open Access content15
    Cristina Masuet-Aumatell, Stephen Toovey, Jane N. Zuckerman, Prevention of influenza among travellers attending at a UK travel clinic: beliefs and perceptions. A cross-sectional study, Influenza and Other Respiratory Viruses, 2013, 7, 4
  16. 16
    P.G. Van Buynder, S. Konrad, J.L. Van Buynder, E. Brodkin, M. Krajden, G. Ramler, M. Bigham, The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly, Vaccine, 2013, 31, 51, 6122

    CrossRef

  17. 17
    Claude Hannoun, The evolving history of influenza viruses and influenza vaccines, Expert Review of Vaccines, 2013, 12, 9, 1085

    CrossRef

  18. 18
    Derek T O’Hagan, Gary S Ott, Gary Van Nest, Rino Rappuoli, Giuseppe Del Giudice, The history of MF59®adjuvant: a phoenix that arose from the ashes, Expert Review of Vaccines, 2013, 12, 1, 13

    CrossRef

  19. 19
    Natalie Pica, Peter Palese, Toward a Universal Influenza Virus Vaccine: Prospects and Challenges, Annual Review of Medicine, 2013, 64, 1, 189

    CrossRef

  20. 20
    Florian Krammer, Peter Palese, Universal influenza virus vaccines: need for clinical trials, Nature Immunology, 2013, 15, 1, 3

    CrossRef

  21. 21
    Jan P. Radomski, Piotr P. Slonimski, Alignment free characterization of the influenza-A hemagglutinin genes by the ISSCOR method, Comptes Rendus Biologies, 2012, 335, 3, 180

    CrossRef

  22. 22
    Sehee Park, Jin Il Kim, Man-Seong Park, Antiviral Agents Against Influenza Viruses, Journal of Bacteriology and Virology, 2012, 42, 4, 284

    CrossRef

  23. 23
    Hartmut J. Ehrlich, Gregory Berezuk, Sandor Fritsch, Gerald Aichinger, Julia Singer, Daniel Portsmouth, Mary Kate Hart, Wael El-Amin, Otfried Kistner, P. Noel Barrett, Clinical development of a Vero cell culture-derived seasonal influenza vaccine, Vaccine, 2012, 30, 29, 4377

    CrossRef

  24. 24
    Giancarlo Icardi, Andrea Orsi, Antonella Ceravolo, Filippo Ansaldi, Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system, Human Vaccines & Immunotherapeutics, 2012, 8, 1, 67

    CrossRef

  25. 25
    Carolien E. van de Sandt, Joost H. C. M. Kreijtz, Guus F. Rimmelzwaan, Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses, Viruses, 2012, 4, 12, 1438

    CrossRef

  26. 26
    Xiangjun Du, Libo Dong, Yu Lan, Yousong Peng, Aiping Wu, Ye Zhang, Weijuan Huang, Dayan Wang, Min Wang, Yuanji Guo, Yuelong Shu, Taijiao Jiang, Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation, Nature Communications, 2012, 3, 709

    CrossRef

  27. 27
    Jin Il Kim, Man-Seong Park, N-Linked Glycosylation in the Hemagglutinin of Influenza A Viruses, Yonsei Medical Journal, 2012, 53, 5, 886

    CrossRef

  28. 28
    Benjamin Petsch, Margit Schnee, Annette B Vogel, Elke Lange, Bernd Hoffmann, Daniel Voss, Thomas Schlake, Andreas Thess, Karl-Josef Kallen, Lothar Stitz, Thomas Kramps, Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection, Nature Biotechnology, 2012, 30, 12, 1210

    CrossRef

  29. 29
    Yolanda D. Mahnke, Areej Saqr, Staci Hazenfeld, Rebecca C. Brady, Mario Roederer, Ramu A. Subbramanian, Age-related changes in durability and function of vaccine-elicited influenza-specific CD4+ T-cell responses, Vaccine, 2011, 29, 47, 8606

    CrossRef

  30. 30
    M. R. Sandbulte, K. B. Westgeest, J. Gao, X. Xu, A. I. Klimov, C. A. Russell, D. F. Burke, D. J. Smith, R. A. M. Fouchier, M. C. Eichelberger, Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses, Proceedings of the National Academy of Sciences, 2011, 108, 51, 20748

    CrossRef

  31. 31
    J.H.C.M. Kreijtz, R.A.M. Fouchier, G.F. Rimmelzwaan, Immune responses to influenza virus infection, Virus Research, 2011, 162, 1-2, 19

    CrossRef

  32. 32
    Valentina Parodi, Daniela de Florentiis, Mariano Martini, Filippo Ansaldi, Inactivated Influenza Vaccines, Drugs & Aging, 2011, 28, 2, 93

    CrossRef

  33. 33
    Filippo Ansaldi, Paolo Durando, Giancarlo Icardi, Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement, Expert Opinion on Biological Therapy, 2011, 11, 3, 415

    CrossRef

  34. 34
    Derek T O’Hagan, Rino Rappuoli, Ennio De Gregorio, Theodore Tsai, Giuseppe Del Giudice, MF59 adjuvant: the best insurance against influenza strain diversity, Expert Review of Vaccines, 2011, 10, 4, 447

    CrossRef

  35. 35
    John Steel, New Strategies for the Development of H5N1 Subtype Influenza Vaccines, BioDrugs, 2011, 25, 5, 285

    CrossRef

  36. 36
    T. K. Berthoud, M. Hamill, P. J. Lillie, L. Hwenda, K. A. Collins, K. J. Ewer, A. Milicic, H. C. Poyntz, T. Lambe, H. A. Fletcher, A. V. S. Hill, S. C. Gilbert, Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1, Clinical Infectious Diseases, 2011, 52, 1, 1

    CrossRef

  37. 37
    Thomas Han, Wayne A. Marasco, Structural basis of influenza virus neutralization, Annals of the New York Academy of Sciences, 2011, 1217, 1
  38. 38
    A. Osterhaus, R. Fouchier, G. Rimmelzwaan, Towards universal influenza vaccines?, Philosophical Transactions of the Royal Society B: Biological Sciences, 2011, 366, 1579, 2766

    CrossRef

  39. 39
    Xiaoming Song, Jian Chen, Kedsirin Sakwiwatkul, Ruili Li, Songhua Hu, Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re, International Immunopharmacology, 2010, 10, 3, 351

    CrossRef

  40. 40
    Zichria Zakay-Rones, Human influenza vaccines and assessment of immunogenicity, Expert Review of Vaccines, 2010, 9, 12, 1423

    CrossRef

  41. 41
    Gokhan Temiz, Nilgun Kasifoglu, Alpay Kiris, Sultan Ozkurt, Garip Sahin, Ahmet Ugur Yalcin, Tercan Us, Immune response after a single vaccination against 2009 influenza A H1N1 in hemodialysis patients, Renal Failure, 2010, 32, 6, 716

    CrossRef

  42. 42
    Vincenzo Baldo, Tatjana Baldovin, Michele Pellegrini, Gabriele Angiolelli, Silvia Majori, Annarosa Floreani, Marta Cecilia Busana, Chiara Bertoncello, Renzo Trivello, Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents, Clinical and Developmental Immunology, 2010, 2010, 1

    CrossRef

  43. You have free access to this content43
    G. D. Deans, H. G. Stiver, J. E. McElhaney, Influenza vaccines provide diminished protection but are cost-saving in older adults, Journal of Internal Medicine, 2010, 267, 2
  44. 44
    Gert Zimmer, RNA Replicons - A New Approach for Influenza Virus Immunoprophylaxis, Viruses, 2010, 2, 2, 413

    CrossRef

  45. 45
    Arnold S. Monto, Seasonal influenza vaccinations: specialized products for different target groups, Vaccine, 2010, 28, D14

    CrossRef

  46. 46
    Natalija Budimir, Tjarko Meijerhof, Jan Wilschut, Anke Huckriede, Aalzen de Haan, The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes, Vaccine, 2010, 28, 52, 8280

    CrossRef

  47. 47
    C. Guillonneau, J. D. Mintern, F.-X. Hubert, A. C. Hurt, G. S. Besra, S. Porcelli, I. G. Barr, P. C. Doherty, D. I. Godfrey, S. J. Turner, Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity, Proceedings of the National Academy of Sciences, 2009, 106, 9, 3330

    CrossRef

  48. 48
    Frederick R Vogel, Catherine Caillet, Inca C Kusters, Jean Haensler, Emulsion-based adjuvants for influenza vaccines, Expert Review of Vaccines, 2009, 8, 4, 483

    CrossRef

  49. 49
    Yuri Ghendon, Stanislav Markushin, Yuri Vasiliev, Irina Akopova, Irina Koptiaeva, Georgy Krivtsov, Olga Borisova, Nelly Ahmatova, Ekaterina Kurbatova, Svetlana Mazurina, Valentina Gervazieva, Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally, Journal of Medical Virology, 2009, 81, 3
  50. 50
    J. Ongrádi, B. Stercz, Valéria Kövesdi, L. Vértes, Immunosenescence and vaccination of the elderly II. New strategies to restore age-related immune impairment, Acta Microbiologica et Immunologica Hungarica, 2009, 56, 4, 301

    CrossRef

  51. 51
    Sheng-Fan Wang, Yuan-Ming Lee, Yu-Jiun Chan, Hsin-Fu Liu, Yung-Fong Yen, Wu-Tse Liu, Jason C. Huang, Yi-Ming Arthur Chen, Influenza A virus in Taiwan, 1980–2006: Phylogenetic and antigenic characteristics of the hemagglutinin gene, Journal of Medical Virology, 2009, 81, 8
  52. 52
    Arnold S. Monto, Filippo Ansaldi, Richard Aspinall, Janet E. McElhaney, Luis F. Montaño, Kristin L. Nichol, Joan Puig-Barberà, Joe Schmitt, Iain Stephenson, Influenza control in the 21st century: Optimizing protection of older adults, Vaccine, 2009, 27, 37, 5043

    CrossRef

  53. You have full text access to this Open Access content53
    Wy Ching Ng, Brad Gilbertson, Bock Lim, Weiguang Zeng, David C. Jackson, Lorena E. Brown, Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenza, Influenza and Other Respiratory Viruses, 2009, 3, 4
  54. 54
    Lorena E Brown, Anne Kelso, Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes, Immunology and Cell Biology, 2009, 87, 4, 300

    CrossRef

  55. 55
    Y. Ghendon, S. Markushin, G. Krivtsov, I. Akopova, Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines, Archives of Virology, 2008, 153, 5, 831

    CrossRef

  56. 56
    Filippo Ansaldi, Sabrina Bacilieri, Paolo Durando, Laura Sticchi, Laura Valle, Emanuele Montomoli, Giancarlo Icardi, Roberto Gasparini, Pietro Crovari, Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses, Vaccine, 2008, 26, 12, 1525

    CrossRef

  57. 57
    James E. Drummond, Eric E. Shaw, Joseph M. Antonello, Tina Green, Gerald J. Page, Cliff O. Motley, Keith A. Wilson, Adam C. Finnefrock, Xiaoping Liang, Danilo R. Casimiro, Design and optimization of a multiplex anti-influenza peptide immunoassay, Journal of Immunological Methods, 2008, 334, 1-2, 11

    CrossRef

  58. You have full text access to this Open Access content58
    Angelika Banzhoff, Michele Pellegrini, Giuseppe Del Giudice, Elena Fragapane, Nicola Groth, Audino Podda, MF59®-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis, Influenza and Other Respiratory Viruses, 2008, 2, 6
  59. 59
    Monika Redlberger, Stephan W. Aberle, Franz X. Heinz, Therese Popow-Kraupp, Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria, Vaccine, 2007, 25, 32, 6061

    CrossRef

  60. You have free access to this content60
    AL Gruver, LL Hudson, GD Sempowski, Immunosenescence of ageing, The Journal of Pathology, 2007, 211, 2
  61. 61
    Martha I. Nelson, Edward C. Holmes, The evolution of epidemic influenza, Nature Reviews Genetics, 2007, 8, 3, 196

    CrossRef

  62. 62
    A.M. Iorio, M. Neri, E. Lepri, B. Camilloni, M. Basileo, N. Sigismondi, C. Fabiani, L. Calzoletti, S. Puzelli, I. Donatelli, An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home, Vaccine, 2006, 24, 44-46, 6615

    CrossRef

  63. 63
    M. F Boni, J. R Gog, V. Andreasen, M. W Feldman, Epidemic dynamics and antigenic evolution in a single season of influenza A, Proceedings of the Royal Society B: Biological Sciences, 2006, 273, 1592, 1307

    CrossRef

  64. 64
    Birger Trollfors, General vaccination of children against influenza?, Acta Paediatrica, 2006, 95, 7
  65. 65
    Fusheng Li, Uma Malhotra, Peter B. Gilbert, Natalie R. Hawkins, Ann C. Duerr, Juliana M. McElrath, Lawrence Corey, Steven G. Self, Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation, Vaccine, 2006, 24, 47-48, 6893

    CrossRef

  66. 66
    Beate Sander, Frederick G Hayden, Marlene Gyldmark, Louis P Garrison, Post-Exposure Influenza Prophylaxis with Oseltamivir, PharmacoEconomics, 2006, 24, 4, 373

    CrossRef

  67. 67
    Judith Legrand, Elisabeta Vergu, Antoine Flahault, Real-time monitoring of the influenza vaccine field effectiveness, Vaccine, 2006, 24, 44-46, 6605

    CrossRef

  68. 68
    Kristin L Nichol, Influenza Vaccination in the Elderly, Drugs & Aging, 2005, 22, 6, 495

    CrossRef

  69. 69
    Herman J Bueving, Siep Thomas, Johannes C van der Wouden, Is influenza vaccination in asthma helpful?, Current Opinion in Allergy and Clinical Immunology, 2005, 5, 1, 65

    CrossRef

  70. 70
    Filippo Ansaldi, Sabrina Bacilieri, Daniela Amicizia, Laura Valle, Federica Banfi, Paolo Durando, Laura Sticchi, Roberto Gasparini, Giancarlo Icardi, Pietro Crovari, Antigenic characterisation of influenza B virus with A new microneutralisation assay: Comparison to haemagglutination and sequence analysis, Journal of Medical Virology, 2004, 74, 1
  71. 71
    N.P.J Vogtländer, A Brown, R.M Valentijn, G.F Rimmelzwaan, A.D.M.E Osterhaus, Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients, Vaccine, 2004, 22, 17-18, 2199

    CrossRef

  72. 72
    Filippo Ansaldi, Pierlanfranco D'Agaro, Daniela de Florentiis, Piero Lai, Pamela Morelli, Daniela Amicizia, Ornella Righello, Giorgia Ferro, Sabrina Bacilieri, Domenico Micillo, Cesare Campello, Pietro Crovari, The emergence of a new influenza A/H3N2 virus variant in northern Italy: which impact on non- and vaccinated population?, International Congress Series, 2004, 1263, 325

    CrossRef

  73. 73
    Suzanne L Epstein, Control of influenza virus infection by immunity to conserved viral features, Expert Review of Anti-infective Therapy, 2003, 1, 4, 627

    CrossRef

  74. 74
    J. A. Antonen, R. Pyhala, P. M. Hannula, I. O. Ala-Houhala, R. Santanen, N. Ikonen, H. H. T. Saha, Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults, Nephrology Dialysis Transplantation, 2003, 18, 4, 777

    CrossRef

  75. 75
    H.F. Berg, J. Van Gendt, G.F. Rimmelzwaan, M.F. Peeters, P. Van Keulen, Nosocomial Influenza Infection among Post-influenza-vaccinated Patients with Severe Pulmonary Diseases, Journal of Infection, 2003, 46, 2, 129

    CrossRef

  76. 76
    Terry Nolan, Min-Shi Lee, Julie M Cordova, Iksung Cho, Robert E Walker, Marilyn J August, Susan Larson, Kathleen L Coelingh, Paul M Mendelman, Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities, Vaccine, 2003, 21, 11-12, 1224

    CrossRef

  77. 77
    Thorsten Wolff, René Snacken, Viral Infections and Treatment, 2003,

    CrossRef

  78. 78
    David J.D. Earn, Jonathan Dushoff, Simon A. Levin, Ecology and evolution of the flu, Trends in Ecology & Evolution, 2002, 17, 7, 334

    CrossRef

  79. 79
    A.C.M. Boon, E. Fringuelli, Y.M.F. Graus, R.A.M. Fouchier, K. Sintnicolaas, A.M. Iorio, G.F. Rimmelzwaan, A.D.M.E. Osterhaus, Influenza A Virus Specific T Cell Immunity in Humans during Aging, Virology, 2002, 299, 1, 100

    CrossRef

  80. 80
    Alan W. Hampson, Influenza, 2002,

    CrossRef

  81. 81
    G.F. Rimmelzwaan, M. Baars, G. van Amerongen, R. van Beek, A.D.M.E. Osterhaus, A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses, Vaccine, 2001, 20, 1-2, 158

    CrossRef

  82. 82
    R. Pyhälä, M. Haanpää, M. Kleemola, R. Tervahauta, R. Visakorpi, L. Kinnunen, Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match, Vaccine, 2001, 19, 23-24, 3253

    CrossRef

  83. 83
    J.C. de Jong, W.E.P. Beyer, A.M. Palache, G.F. Rimmelzwaan, A.D.M.E. Osterhaus, Antibody responses in elderly to influenza vaccination in case of an antigenic mismatch, International Congress Series, 2001, 1219, 707

    CrossRef

  84. 84
    Suryaprakash Sambhara, Anjna Kurichh, Renata Miranda, Terrence Tumpey, Thomas Rowe, Mary Renshaw, Rita Arpino, Alan Tamane, Ali Kandil, Olive James, Brian Underdown, Michel Klein, Jacqueline Katz, David Burt, Heterosubtypic Immunity against Human Influenza A Viruses, Including Recently Emerged Avian H5 and H9 Viruses, Induced by FLU–ISCOM Vaccine in Mice Requires both Cytotoxic T-Lymphocyte and Macrophage Function, Cellular Immunology, 2001, 211, 2, 143

    CrossRef

  85. 85
    J.C. de Jong, G.F. Rimmelzwaan, R.A.M. Fouchier, A.D.M.E. Osterhaus, Influenza Virus: a Master of Metamorphosis, Journal of Infection, 2000, 40, 3, 218

    CrossRef

  86. 86
    Ren?? Snacken, Managing Influenza in Primary Care, Disease Management and Health Outcomes, 2000, 8, 2, 79

    CrossRef

  87. 87
    Noa Eliakim-Raz, Inbal Vinograd, Anca Zalmanovici Trestioreanu, Leonard Leibovici, Mical Paul, Influenza vaccines in immunosuppressed adults with cancer, The Cochrane Library,